3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and oxidopamine

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with oxidopamine in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (75.00)18.2507
2000's2 (16.67)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kunow, M; Löschmann, PA; Wachtel, H1
Honoré, T; Jähnig, P; Jenner, P; Kunow, M; Lange, KW; Löschmann, PA; Marsden, CD; Rettig, KJ; Turski, L; Wachtel, H1
Gancher, S; Mayer, A1
Carta, A; Fenu, S; Morelli, M1
Emmi, A; Rajabi, H; Stewart, J1
Klockgether, T; Löschmann, PA; Petersen, V; Steinbach, JP; Turski, L; Wüllner, U1
Bergstrom, DA; Huang, KX; Ruskin, DN; Walters, JR1
Pollack, AE; Strauss, JB1
Dewar, KM; Elie, R; Vasiliadis, HM1
Marshall, JF; Schuller, JJ1
Haisley, EC; Pollack, AE1
Akita, H; Honda, Y; Noda, K; Ogata, M; Saji, M1

Other Studies

12 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and oxidopamine

ArticleYear
NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats.
    Neuroscience letters, 1992, Aug-17, Volume: 142, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Apomorphine; Dopamine Agents; Drug Synergism; Ibotenic Acid; Lisuride; Male; Neurons; Oxidopamine; Parkinson Disease, Secondary; Piperazines; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Substantia Nigra; Sympathectomy, Chemical

1992
Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease.
    Journal of neural transmission. Parkinson's disease and dementia section, 1991, Volume: 3, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Callithrix; Disease Models, Animal; Drug Synergism; Ibotenic Acid; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Piperazines; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Substantia Nigra

1991
Sensitization to apomorphine-induced rotational behavior in 6-OHDA-lesioned rats: effects of NMDA antagonists on drug response.
    Brain research, 1995, Jun-05, Volume: 682, Issue:1-2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Male; N-Methylaspartate; Oxidopamine; Piperazines; Rats; Rats, Sprague-Dawley; Rotation; Stereotyped Behavior; Sympathectomy, Chemical

1995
Modulation of dopamine D1-mediated turning behavior and striatal c-fos expression by the substantia nigra.
    Synapse (New York, N.Y.), 1995, Volume: 19, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Dizocilpine Maleate; Immunohistochemistry; Injections; Male; Neostriatum; Oxidopamine; Piperazines; Proto-Oncogene Proteins c-fos; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Substantia Nigra; Sympathectomy, Chemical

1995
Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1996, Aug-15, Volume: 16, Issue:16

    Topics: Animals; Behavior, Animal; Dizocilpine Maleate; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Male; Oxidopamine; Piperazines; Rats; Rats, Wistar; Substantia Nigra

1996
Effects of the antiparkinsonian drug budipine on central neurotransmitter systems.
    European journal of pharmacology, 1996, Apr-22, Volume: 301, Issue:1-3

    Topics: Animals; Antiparkinson Agents; Biperiden; Central Nervous System; Dopamine; Excitatory Amino Acid Antagonists; Male; Mice; Microdialysis; Muscarinic Antagonists; N-Methylaspartate; Neostriatum; Neurotransmitter Agents; Oxidopamine; Piperazines; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Rotation; Seizures; Stereotyped Behavior; Sympatholytics

1996
N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Synapse (New York, N.Y.), 1998, Volume: 30, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Male; Neurons; Oxidopamine; Parkinson Disease, Secondary; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Reserpine; Stereotaxic Techniques; Substantia Nigra

1998
Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Brain research, 1999, May-08, Volume: 827, Issue:1-2

    Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Corpus Striatum; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Male; Nerve Degeneration; Oxidopamine; Piperazines; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Rotation; Sympatholytics; Time Factors

1999
Interaction between dopamine and glutamate receptors following treatment with NMDA receptor antagonists.
    European journal of pharmacology, 1999, Dec-15, Volume: 386, Issue:2-3

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzamides; Benzazepines; Dizocilpine Maleate; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Female; Oxidopamine; Piperazines; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptors, AMPA; Receptors, Dopamine; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Tritium

1999
Acute immediate-early gene response to 6-hydroxydopamine infusions into the medial forebrain bundle.
    Neuroscience, 2000, Volume: 96, Issue:1

    Topics: Animals; Basal Ganglia; Behavior, Animal; Excitatory Amino Acid Antagonists; Gene Expression; Genes, Immediate-Early; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sensation; Time Factors

2000
NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats.
    Brain research, 2001, Apr-06, Volume: 897, Issue:1-2

    Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Denervation; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Male; Oxidopamine; Parkinson Disease; Piperazines; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Sympatholytics

2001
Activation of the NMDA receptor involved in the alleviating after-effect of repeated stimulation of the subthalamic nucleus on motor deficits in hemiparkinsonian rats.
    Brain research, 2010, Jan-08, Volume: 1306

    Topics: Animals; Deep Brain Stimulation; Dizocilpine Maleate; Dyskinesias; Excitatory Amino Acid Antagonists; Forelimb; Male; Motor Activity; Neuropsychological Tests; Oxidopamine; Parkinsonian Disorders; Piperazines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Subthalamic Nucleus; Time Factors

2010